[Experimental study of human amniotic mesenchymal stem cell exosome promoting fibroblasts migration through

Tao Chen1, Shaoying Gao1, Yi Hao1

  • 1Department of Burn and Plastic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi Guizhou, 563000, P.R.China.

Abstract

Insights

MicroRNA-135a (miR-135a) within human amnion mesenchymal stem cell exosomes (hAMSC-Exo) promotes fibroblast migration. This involves regulating key proteins like E-cadherin and α-SMA, impacting cellular movement.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biotechnology

Background:

  • Mesenchymal stem cell-derived exosomes are investigated for therapeutic potential.
  • Exosomes contain microRNAs that can modulate recipient cell functions.
  • Fibroblast migration is crucial in wound healing and tissue repair.

Purpose of the Study:

  • To determine the role of microRNA-135a (miR-135a) carried by human amnion mesenchymal stem cell exosomes (hAMSC-Exo) in regulating fibroblast migration.
  • To elucidate the molecular mechanisms underlying hAMSC-Exo mediated fibroblast migration.

Main Methods:

  • hAMSC-Exosomes were isolated and characterized.
  • Fibroblast migration was assessed using scratch assays.
  • miR-135a expression levels were manipulated (overexpression and knockdown) in hAMSC-Exo.
  • Protein expression of migration-related markers (LATS2, E-cadherin, N-cadherin, α-SMA) was analyzed via Western blot.

Main Results:

  • hAMSC-Exo significantly enhanced fibroblast migration.
  • Overexpression of miR-135a in hAMSC-Exo further boosted fibroblast migration, while knockdown diminished this effect.
  • hAMSC-Exo treatment altered the expression of key proteins: decreased E-cadherin, N-cadherin, and LATS2, and increased α-SMA, with miR-135a levels correlating with these changes.

Conclusions:

  • miR-135a within hAMSC-Exo acts as a key mediator promoting fibroblast migration.
  • The study demonstrates that miR-135a in hAMSC-Exo influences fibroblast migration by modulating the expression of E-cadherin, N-cadherin, LATS2, and α-SMA.
  • These findings highlight the potential of hAMSC-Exo as a therapeutic agent for conditions involving fibroblast migration.